Latest posts tagged with #CyPathLung on Bluesky
Dr Michael Nicholson shares real-world insights on using the noninvasive CyPath® Lung test for #lungcancer in clinical practice. Watch w/ free @VuMedi subscription at bit.ly/4qk8txm
$BIAF #pulmonology #CyPathLung #earlydetection
Lung cancer experts stress the importance of lung cancer screening and value of expanding screening criteria to include more at-risk individuals. See the article in Oncology Live at bit.ly/4k5NBbA and how CyPath® Lung can help at www.cypathlung.com
#lungcancerscreening #CyPathLung #BIAF #lungcancer
Only 12% of high-risk Texans receive recommended lung cancer screening — ranking Texas 46th nationally. Early detection and access matter.
Read the American Lung Association report at bit.ly/4qVmRwy
#lungcancer #EarlyDetection #HealthEquity #Diagnostics #PublicHealth #TexasHealthcare #CyPathLung
Barry Manilow's recent disclosure of his lung cancer diagnosis underscored a powerful truth: early detection saves lives.
At #CyPathLung, we’re advancing a noninvasive, sputum-based approach to help identify #lungcancer risk as early as Stage 1A.
#earlydetection #BarryManilow
Day 2 at #CHEST2025! Great conversations with clinicians & researchers advancing noninvasive lung diagnostics.
Our team at Booth 2242 is sharing how #CyPathLung uses flow cytometry + #AI to support earlier, more accurate detection of lung cancer.
#bioAffinityTechnologies #LungHealth #Diagnostics
AI is revolutionizing cancer detection. The USPTO plans to grant bioAffinity Technologies a patent for our AI-powered flow cytometry platform that detects lung cancer with precision and consistency. Learn more: bit.ly/42N8CAq
#CyPathLung #cancerdiagnostics #patent #AI
On World Lung Day, we honor patients and families and look forward with hope. CyPath® Lung is committed to earlier detection, so every patient can have more time and more moments.
#WorldLungDay #LungHealth #EarlyDetection #CyPathLung
Indeterminate lung nodules don’t have to mean uncertainty.
CyPath® Lung is a noninvasive sputum test that uses flow cytometry to deliver:
✅92% sensitivity
✅87% specificity
Fewer unnecessary procedures.
Clearer, faster answers.
#LungCancer #EarlyDetection #CyPathLung
CyPath® Lung helped detect a malignancy in ground-glass nodules in a 66-year-old patient with a smoking history, supporting earlier detection and better care.
Watch Dr. Guda’s interview: www.cypathlung.com
#LungCancer #EarlyDetection #CyPathLung #PhysicainHighlights
Ground-glass nodules often mean years of “watchful waiting.” In a new case, CyPath® Lung delivered actionable results that led to timely lung cancer diagnosis and treatment.
Read more: bit.ly/3JNK181
#LungCancer #Diagnostics #CyPathLung
We are honored to be featured in U.S. Medicine. New issue includes a story on the economic impact of our #CyPathLung test for #lungcancer.
See our press release at bit.ly/47tdq12
See the US Medicine story at bit.ly/41XHLRR
#innovation #pulmonology #veterans
Proud to see CyPath® Lung featured in U.S. Medicine’s August pulmonary issue.
Our noninvasive test can help veterans, 3x more likely to qualify for lung cancer screening, by improving detection, reducing unnecessary follow-ups & ⬇️costs.
📖 bit.ly/4mKrTKO
#LungCancer #VeteransHealth #CyPathLung
Indeterminate lung nodules can be difficult to assess by CT or PET imaging. CyPath® Lung detects cancer in nodules <20mm with 92% sensitivity & 87% specificity which helps physicians catch malignancy earlier for better patient outcomes. bit.ly/IsraelGarcia
#CyPathLung #LungCancer #EarlyDetection
Wrapped up #AABIP2025 sharing how CyPath® Lung helps detect lung cancer early, when treatment is most effective.
Grateful for the conversations, collaborations & commitment to advancing lung health.
#LungCancer #EarlyDetection #CyPathLung #PatientCare
Looking forward to connecting at AABIP 2025 Conference 8/14. Visit Booth 44 to learn how physicians use CyPath® Lung as a noninvasive diagnostic tool to support early detection of lung cancer and improve patient care.
#CyPathLung #LungCancer #EarlyDetection #AABIP2025 #PatientCare
When a CyPath® Lung sample delay arose, our team jumped into action, ensuring safe, timely delivery to the lab. When patient care is at the heart of our team, it can’t skip a beat. ❤️
#CyPathLung #LungCancer #PrecisionPathology #Teamwork #PatientCare
Only 2 days until AABIP! Visit us at Booth 44 to hear how CyPath® Lung is helping physicians detect lung cancer early, noninvasively, and with accuracy you can trust.
We’ll see you there!
#CyPathLung #LungCancer #EarlyDetection #AABIP
With something as essential as breath, every moment matters.
Early detection saves lives. Let’s keep pushing for awareness and action.
#WorldLungCancerDay #EarlyDetection #LungCancerAwareness #CyPathLung
“CyPath® Lung gave us the clarity we needed to act early,” said Dr. Gordon Downie, CMO, referring to a Stage 1A mucinous adenocarcinoma missed by other diagnostics.
Every early diagnosis is a life potentially saved.
Read the press release: bit.ly/4l6uOvn
#CyPathLung #LungCancer #bioAffinity
New case study: noninvasive CyPath® Lung detected a Stage 1A neuroendocrine tumor that PET, bronchoscopy & serum markers missed, leading to timely surgical removal.
Noninvasive. Precise. Life saving.
Full PR: bit.ly/44MjPCz
#LungCancer #EarlyDetection #CyPathLung #PhysicianHighlights
Canada awards patent for CyPath® Lung, expanding global protection of our noninvasive test for early lung cancer detection. With 92% sensitivity and 88% accuracy, early diagnosis can save lives. PR: bit.ly/CanadaPatent
#CyPathLung #LungCancer #Diagnostics #Biotech #Canada
CyPath® Lung gives physicians timely, actionable insights for patients at risk of lung cancer. Early detection is critical and fast results save lives.
Noninvasive. Accurate Results.
See how Dr. Nadarajah uses CyPath® Lung: bit.ly/DrNadarajah
#CyPathLung #LungCancer #PhysicianHighlights
Quick, accurate, and patient-centered.
CyPath® Lung delivers actionable results in just 3 days empowering better clinical decisions, faster.
See what NP Israel Garcia says about its impact on care.
Check it out: bit.ly/IsraelGarcia
#CyPathLung #LungCancer #EarlyDetection #PhysicianHighlights
CyPath® Lung detected Stage 1A lung cancer and gave “the confidence to intervene surgically when everything else pointed to watchful waiting,” -Dr. Gordon Downie
Early detection led to timely care. Read the press release: bit.ly/3TsciT5
#CyPathLung #EarlyDetection #LungCancer #PhysicianHighlights
92% sensitivity, 87% specificity in detecting lung cancer in high-risk patients with nodules <20mm.
Backed by data. Trusted by physicians.
Built for market growth.
Learn more: bit.ly/3I9i3mg
#CyPathLung #CancerDiagnostics #LungCancer #InvestorInsight
Today, we honor #Juneteenth, marking a pivotal moment in our history. Inspired by this spirit of resilience, bioAffinity is committed to advancing health solutions that serve all communities in their journey towards health and well-being.
#Juneteenth2025 #EquityInHealth #CyPathLung
Happy Father's Day from CyPath Lung! Celebrating all the amazing dads today. Our work in lung health aims to help keep you healthy for many more years to come. Enjoy your day!
#FathersDay #LungHealth #CyPathLung #Dads
Maria will bring her expertise in lung health & business to advance the ALA's mission. We're committed to noninvasive diagnostics like CyPath® Lung to save lives. Congratulations Maria!
Read it: bit.ly/3Zq8LYN
#CyPathLung #bioAffinity #LungHealth #LungCancer #ALA #Healthcare
